N/A
N=131
Mechanisms of Severe Acute Influenza Consortium (MOSAIC)
Influenza
Bottom Line
View on ClinicalTrials.gov: NCT00965354 ↗Enrolled (actual)
131
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcome: Primary: Number of Patients With Clinical Phenotype Presenting Also a Sequential Activation of Immune/Infammatory Pathways. — 131 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Imperial College London
- Primary completion
- Feb 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients With Clinical Phenotype Presenting Also a Sequential Activation of Immune/Infammatory Pathways. |
131 | — |
Summary
The ultimate goal of this collaborative, intensive study is to discover new and effective treatments and to develop better vaccines that can be used in future outbreaks of Influenza A. By integrating the information that we will gather, we will create a unique overview of how influenza causes illness and what might be done to improve patient management.
Eligibility Criteria
Inclusion Criteria
- Any patient admitted to hospital with suspected or confirmed influenza infection
Exclusion Criteria
- Patients who do not give their consent
Data sourced from ClinicalTrials.gov (NCT00965354). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.